Abstract
Obstructive sleep apnea (OSA) results from increased resistance and/or collapsibility of the upper airway, leading to sleep-related breathing abnormalities that negatively impact the quality of sleep. Guilleminault and colleagues first described the entity of pediatric OSA in 1976 in a series of eight overtly affected children demonstrating apnea in sleep. While clinical definitions of OSA vary, polysomnographically detected apneas and hypopneas on overnight testing—the apnea-hypopnea index (AHI)—are generally understood as a starting point to understand OSA. Now, current understanding of abnormal breathing in sleep is broader than this original description, with recognition that in addition to apneas and hypopneas, nonhypoxic abnormalities such as habitual snoring, increased respiratory effort associated with arousals from sleep or autonomic nervous system alteration, excessive inspiratory nasal flow limitation, impairment of nasal breathing with habitual mouth breathing in sleep, altered inspiratory-to-expiratory time ratio, accessory expiratory muscle activity, tachypnea, and alterations in surrogate measures of PaCO2 may have important roles in defining the syndrome. Collectively, this spectrum of abnormalities and associated symptoms may be termed sleep-disordered breathing (SDB).
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Pediatric
- Sleep-disordered breathing
- Obstructive sleep apnea
- Upper airway resistance syndrome
- Flow limitation
- Apnea
- Hypopnea
- Respiratory effort-related arousal
- Apnea-hypopnea index
- Respiratory disturbance index
First Description and Consensus Definitions for Obstructive Sleep Apnea in Pediatrics
In 1976, Guilleminault and colleagues authored the first definitive report of pediatric obstructive sleep apnea (OSA), describing a series of eight children ranging in age from 5 to 14 years who had loud snoring, breathing pauses in sleep, daytime symptoms including sleepiness, altered school performance, daytime behavior, morning headache, abnormal weight, and progressive development of hypertension as well as enuresis, in association with polysomnographic evidence of respiratory abnormalities similar to those seen in adult OSA [1]. In these children, respiration was reported to be normal during wake, but in sleep, marked abnormalities were observed, including apneas, or cessation of breathing, dozens to hundreds of times on a single night, in association with greatly disturbed sleep, a reduction of slow wave sleep, and sinus arrhythmia [2]. These early publications helped initiate use of the term OSA “syndrome,” or OSAS.
About 20 years later, the American Thoracic Society described pediatric obstructive sleep apnea syndrome as “a disorder of breathing during sleep characterized by prolonged partial upper airway obstruction and/or intermittent complete obstruction (obstructive apnea) that disrupt normal ventilation during sleep and normal sleep patterns” [3]. The most recent definition of pediatric OSA from the American Academy of Sleep Medicine (AASM) includes the following parameters: the presence of snoring; labored, paradoxical, or obstructed breathing during sleep; and/or sleepiness, hyperactivity, behavioral problems, or learning problems; plus polysomnographic evidence of one or more obstructive apneas, mixed apneas, or hypopneas per hour of sleep (i.e., an AHI ≥1), or a pattern of obstructive hypoventilation [4]. Obstructive hypoventilation is further given to be constituted by at least 25% of total sleep time with hypercapnia (PaCO2 >50 mmHg (N.B. a surrogate noninvasive measure for arterial CO2 may be used per AASM Manual for Scoring of Sleep and Associated Events) in association with either snoring; flattening of the inspiratory nasal pressure waveform, a phenomenon known as “flow limitation” (Fig. 34.1), and/or paradoxical thoracoabdominal motion [4]. These criteria apply to those under the age of 18 years.
Within this definition, several types of abnormal respiratory events are relevant, with the essential underlying factor of each being increased upper airway resistance. These include the following:
-
Apneas, defined as a drop in oronasal thermal airflow peak signal excursion by ≥90% of pre-event baseline. Obstructive apnea is scored for pediatrics if the event is at least two breaths in duration and associated with respiratory effort throughout the entire period; if respiratory effort is absent for part of this duration, a mixed apnea is scored [5].
-
Hypopneas, defined as a peak signal excursion drop of at least 30% from pre-event baseline using the nasal pressure or alternate sensor, for at least 2 breaths; associated with either a ≥3% oxygen desaturation or an EEG arousal. Unlike apneas, hypopneas need not be subdivided into obstructive or central etiology, as it is not possible to definitely determine contributions from reduced central drive or increased airway resistance without a direct quantitative measure of effort (such as esophageal manometry). Nonetheless, obstructive hypopneas in particular are suggested by presence of snoring, inspiratory flow limitation, which is characterized by flattening of the nasal pressure inspiratory waveform, or induction of paradoxical thoracoabdominal movement associated with the event [5]. Regarding hypopneas in particular, studies evaluating OSAS in children must be taken in the context of the era in which they were conducted, as the definition for hypopnea has undergone several iterations in the last 20 years, leading to substantial diagnostic impact. For example, in 2007, the AASM made a key change in terms of scoring hypopneas, altering the threshold for reduction in airflow (30 vs. 50%), which resulted in overall lower OAHIs and putatively reduced OSA severity by approximately 24% of cases in one study, and up to fivefold in another study of 209 children [6, 7].
-
Respiratory effort-related arousals, or RERAs, defined as a sequence of at least two breaths that do not meet criteria for apnea or hypopnea, but are characterized by increasing respiratory effort (classically measured quantitatively by esophageal manometry, as other measures of respiratory effort are not quantitative); inspiratory nasal flow limitation; snoring; of an elevated end-tidal PCO2 above pre-event baseline, in association with an EEG arousal. Inspiratory flow limitation in children with abnormal nocturnal breathing has been shown to be associated with increased respiratory driving pressure (i.e., respiratory effort, as measured by esophageal manometry) and therefore elevated upper airway resistance in both NREM and REM sleep [8]. In fact by 1982, it was already recognized that apneas and hypopneas were inadequate to define the syndrome of OSA seen in children, and defining breathing abnormalities using snoring and “sleep-related respiratory resistive load” had been proposed [9]. Still, even now RERAs are not included in the calculation of apnea-hypopnea index (AHI) , which represents the average of apneas and hypopneas recorded hourly over a single night recording. The Respiratory Disturbance Index (RDI) is more broadly defined, and represents the average of apneas, hypopneas, and RERAs recorded hourly over a single night recording. The presence of RERAs per se, in the absence of overt hypopneas and apneas, and with or without snoring, may give rise to the entity of upper airway resistance syndrome (UARS), in which clinical symptoms of sleep disturbance are associated with increased effort , sleep disturbances, respiratory arrhythmia, altered heart rate variability with altered parasympathetic activity. UARS was described in children over 20 years ago and remains relevant for understanding the clinical manifestations of, and developmental evolution of, sleep breathing disorders [10,11,12].
More recently, then, it has been understood that OSAS should be defined in the broader context of a spectrum of sleep disturbances due to altered upper airway resistance and consequent altered respiration, known collectively as “sleep disordered breathing” (SDB), a term that more aptly reflects diverse presentations. This spectrum may involve habitual snoring, overt apneas and hypopneas, obstructive hypoventilation marked by alterations in surrogate measures of PaCO2, or nonhypoxic increased respiratory effort associated with sleep fragmentation or autonomic nervous system alterations [13,14,15,16]. Increased respiratory effort is well-established as a way to measure to quantify the impact of increased airway resistance, but esophageal manometry, while insightful, is infrequently used in pediatric sleep laboratories, giving rise to interest in additional measures of impaired breathing in sleep.
Additional Elements of Sleep-Related Respiratory Disturbance Not in the Definitions
As noted above, apneas and hypopneas are now recognized to be an incomplete description of respiratory-related sleep disturbance. In 1985, Guilleminault and colleagues reported on 25 children who had daytime symptoms associated with sleep disturbance as well as heavy snoring. Polysomnography did not reveal OSAS or hypoxemia but did demonstrate increased respiratory resistive load during sleep associated with electrocardiographic R-R interval and esophageal pressure swings, with improvement on symptoms after upper airway surgery [9]. More recently, snoring severity itself has been found to correlate with poorer general behavioral and cognitive functional findings independent of AHI among a large cohort of community dwelling children [17].
More subtle but reliable and accessible measures of the breathing abnormalities associated with pediatric SDB exist. These include the presence of tachypnea, inspiratory nasal flow limitation measured by standard nasal pressure transducer; impairment of nasal breathing/habitual mouth breathing in sleep measured using a commercially available oral scoop, altered inspiratory-to-expiratory time ratio, accessory expiratory muscle activity measured by surface EMG, as nasal pressure transducer is an unreliable measure of expiratory flow limitation [13, 18, 19]. Whether these measures, which are generally available clinically in limited locations, can be extended into widespread practice and can be integrated into updates to the definition of pediatric sleep-disordered breathing remains to be seen.
Additionally, measures of sleep stability and fragmentation may also provide advances into defining the syndrome. The current definition of arousal from sleep, for example, is an abrupt shift of EEG frequency including alpha, theta, and/or frequencies greater than 16 Hz for at least 3 seconds, with 10 seconds of stable sleep preceding the change [5]. Arousals described this way are the key element of defining SDB-related sleep fragmentation but may not be sensitive enough to capture important disturbance. Additional, potentially more telling, sleep microstructural changes, that is, cyclic alternating pattern (CAP) rate changes, have been described [20] in association with pediatric SDB, for example [13, 21]. Using more refined measures of the sleep encephalogram in addition to AHI may become more practical with the advent of newer technologies capable of detecting the phenomenon in a less labor intensive and more consistent manner.
Finally, the diagnosis of pediatric OSA currently requires access to a qualified pediatric sleep laboratory, which poses potential access and cost challenges. While history alone has been shown to be insufficient diagnostically, and even recently, an AASM position paper reinforced the inadequacy of home-based sleep testing for the diagnosis of sleep apnea in children, evaluation of home-based assessments of breathing and sleep, in conjunction with clinical evaluation and validated tools, have been reported and may alter the landscape of pediatric OSA definition in the future, especially in resource-limited areas [22,23,24,25,26].
A Look Forward: Challenges to Define Early Signals of Pediatric OSA
While these respiratory abnormalities correspond generally to events scored in OSA defined for adult populations, it should be emphasized that the sleep-disordered breathing in children differs markedly from the syndrome seen in adults, in epidemiology, underlying proximal contributing factors, clinical presentation and associations, polysomnographic and physiologic findings, and largely, in treatment. It has been argued that the spectrum of pediatric sleep breathing disorders represents the earliest manifestations of airway dysfunction that will blossom in adulthood to fully manifested OSAS, with the epidemic of obesity either hastening or initiating this process [15]. Furthermore, the risks for pediatric SDB have been argued to occur as early as in utero, gaining steam throughout early and middle childhood if not corrected [27, 28]. To the extent that this occurs, the manifestations of SDB are not static and unlikely to be defined by simple “events” described by the consensus scoring criteria and manuals, but rather a spectrum of dynamic challenges to the airway and craniofacial complex, autonomic nervous system, and sleep stability. The dynamic interplay of structure and function in pediatrics in particular has given rise to the argument that notion of OSA defined by apneas and hypopneas, and even UARS, are historical, if not just incomplete, as there is already enough knowledge to grow beyond these definitions by recognizing manifestations of sleep respiratory challenges differently, with a focus on secondary prevention [29]. In recognition of these factors, inclusion of degree of nasal flow limitation, oral breathing in sleep, stertor, CAP frequency, and other measures may be utilized clinically in the future to better define the syndrome of sleep disturbance associated with abnormal breathing, especially in those children without associated hypoxia.
References
Guilleminault C, Eldridge FL, Simmons FB, Dement WC. Sleep apnea in eight children. Pediatrics. 1976;58(1):23–30.
Guilleminault C, Tilkian AG, Dement WC. Sleep and respiration in the syndrome “apnea during sleep” in the child. Electroencephalogr Clin Neurophysiol. 1976;41(4):367–78.
American Thoracic Society. Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med. 1996;153:866–78.
International classification of sleep disorders. 3rd ed. Darien: American Academy of Sleep Medicine; 2014. p. 63.
Berry RB, Albertaio CL, Harding SM, for the American Academy of Sleep Medicine, et al. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Version 2.5. Darien: American Academy of Sleep Medicine; 2018.
Nixon GM, Hyde M, Biggs SN, Walter LM, Horne RS, Davey MJ. The impact of recent changes to the respiratory scoring rules in pediatrics. J Clin Sleep Med. 2014;10(11):1217–21.
Lin CH, Guilleminault C. Current hypopnea scoring criteria underscore pediatric sleep disordered breathing. Sleep Med. 2011;12(7):720–9.
Serebrisky D, Cordero R, Mandeli J, Kattan M, Lamm C. Assessment of inspiratory flow limitation in children with sleep-disordered breathing by a nasal cannula pressure transducer system. Pediatr Pulmonol. 2002;33(5):380–7.
Guilleminault C, Winkle R, Korobkin R, Simmons B. Children and nocturnal snoring: evaluation of the effects of sleep related respiratory resistive load and daytime functioning. Eur J Pediatr. 1982;139(3):165–71.
Guilleminault C, Pelayo R, Leger D, Clerk A, Bocian RC. Recognition of sleep-disordered breathing in children. Pediatrics. 1996;98(5):871–82.
Kakar E, Corel LJA, Tasker RC, de Goederen R, Wolvius EB, Mathijssen IMJ, Joosten KFM. Electrocardiographic variables in children with syndromic craniosynostosis and primary snoring to mild obstructive sleep apnea: significance of identifying respiratory arrhythmia during sleep. Sleep Med. 2018;45:1–6.
Lopes MC, Spruyt K, Azevedo-Soster L, Rosa A, Guilleminault C. Reduction in parasympathetic tone during sleep in children with habitual snoring. Front Neurosci. 2019;12:997.
Lopes MC, Guilleminault C. Chronic snoring and sleep in children: a demonstration of sleep disruption. Pediatrics. 2006;118(3):e741–6.
Jambhekar S, Carroll JL. Diagnosis of pediatric obstructive sleep disordered breathing: beyond the gold standard. Expert Rev Respir Med. 2008;2(6):791–809.
Dayyat E, Kheirandish-Gozal L, Gozal D. Childhood obstructive sleep apnea: one or two distinct disease entities? Sleep Med Clin. 2007;2(3):433–44.
Rosen CL. Clinical features of obstructive sleep apnea hypoventilation syndrome in otherwise healthy children. Pediatr Pulmonol. 1999;27(6):403–9.
Smith DL, Gozal D, Hunter SJ, Kheirandish-Gozal L. Frequency of snoring, rather than apnea-hypopnea index, predicts both cognitive and behavioral problems in young children. Sleep Med. 2017;34:170–8.
Lee SY, Guilleminault C, Chiu HY, Sullivan SS. Mouth breathing, “nasal disuse,” and pediatric sleep-disordered breathing. Sleep Breath. 2015;19(4):1257–64.
Guilleminault C, Huang YS, Chin WC, Okorie C. The nocturnal-polysomnogram and “non-hypoxic sleep-disordered-breathing” in children. Sleep Med. 2018. pii: S1389-9457(18)30450-7.
Terzano MG, Parrino L, Sherieri A, et al. Atlas, rules, and recording techniques for the scoring of cyclic alternating pattern (CAP) in human sleep. Sleep Med. 2001;2(6):537–53.
Kheirandish-Gozal L, Miano S, Bruni O, Ferri R, Pagani J, Villa MP, Gozal D. Reduced NREM sleep instability in children with sleep disordered breathing. Sleep. 2007;30(4):450–7.
Marcus CL, Brooks LJ, Draper KA, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130(3):576–84.
Villa MP, Pietropaoli N, Supino MC, et al. Diagnosis of pediatric obstructive sleep apnea syndrome in settings with limited resources. JAMA Otolaryngol Head Neck Surg. 2015;141(11):990–6.
Kirk V, Baughn J, D’Andrea L, et al. American Academy of Sleep Medicine position paper for the use of a home sleep apnea test for the diagnosis of OSA in children. J Clin Sleep Med. 2017;13(10):1199–203.
Norman MB, Pithers SM, Teng AY, et al. Validation of the Sonomat against PSG and quantitative measurement of partial upper airway obstruction in children with sleep-disordered breathing. Sleep. 2014;37(9):1477–87.
Norman MB, Harrison HC, Waters KA, Sullivan CE. Snoring and stertor are associated with more sleep disturbance than apneas and hypopneas in pediatric SDB. Sleep Breath. 2019;23(4):1245–54.
Guilleminault C, Sullivan SS, Huang YS. Sleep-disordered breathing, orofacial growth, and prevention of obstructive sleep apnea. Sleep Med Clin. 2019;14(1):13–20.
Guilleminault C, Huang YS. From oral facial dysfunction to dysmorphism and the onset of pediatric OSA. Sleep Med Rev. 2018;40:203–14.
Arnold WC, Guilleminault C. Upper airway resistance syndrome 2018: non-hypoxic sleep-disordered breathing. Expert Rev Respir Med. 2019;13(4):317–26.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sullivan, S.S., Guilleminault, C. (2021). Obstructive Sleep Apnea: Definition. In: Gozal, D., Kheirandish-Gozal, L. (eds) Pediatric Sleep Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-65574-7_34
Download citation
DOI: https://doi.org/10.1007/978-3-030-65574-7_34
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-65573-0
Online ISBN: 978-3-030-65574-7
eBook Packages: MedicineMedicine (R0)